Avatar for Bikanta

Nanodiamonds Redefining Imaging for Cancer Detection

Nanodiamonds Redefining Imaging for Cancer Detection

Early detection of cancer, & its deadly metastasis, is necessary for increasing the cure rate. Current cancer screening is unable to detect breakaway tumor cells that lead to micrometastatic tumors. Bikanta is introducing a revolutionary nanotechnology platform based on nanodiamonds that empowers researchers & medics to detect & address diseases early at the molecular level.

Nanodiamonds are next generation imaging probes trailblazing cutting-edge research including applications with the recent Nobel Prize in Chemistry for super-resolved fluorescence microscopy & utility in cancer detection devices complementary to Google X's research (goo.gl/HYPsDN), Bikanta's technologies are positioned for significant market penetration into $40-60B R&D markets before large clinical follow-on markets.
Founder & CEO of Bikanta. Post-doctoral fellowships at the National Cancer Institute and National Heart, Lung, & Blood Institute. PhD from University of Oxford.
Founder and CSO of Bikanta Corp. Research focus on regenerative medicine, stem cells and cancer stem cells. PhD from Oxford University.

Bikanta hasn't added any jobs yet

Get notified when Bikanta posts new jobs.

See similar jobs